Simulation of anticoagulation in atrial fibrillation patients with rivaroxaban—from trial to target population
The populations included in the randomized controlled clinical trials and observational studies were different. The effectiveness and safety of rivaroxaban for stroke prevention in patients with atrial fibrillation (AF) varied among studies. This study aimed to estimate the real-world outcomes o...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR (Innovative Medical Research) Press Limited
2021-09-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453106770-1154393521.pdf |